# S0350 Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Peripheral T-Cell Non-Hodgkin's Lymphoma

> **NCT00109928** · PHASE2 · COMPLETED · sponsor: **SWOG Cancer Research Network** · enrollment: 34 (actual)

## Conditions studied

- Lymphoma

## Interventions

- **DRUG:** cisplatin
- **DRUG:** etoposide
- **DRUG:** gemcitabine
- **DRUG:** methylprednisolone

## Key facts

- **NCT ID:** NCT00109928
- **Lead sponsor:** SWOG Cancer Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2012-06
- **Final completion:** 2014-04
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2014-10-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00109928

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00109928, "S0350 Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Peripheral T-Cell Non-Hodgkin's Lymphoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00109928. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*